300584 Nanjing Hicin Pharmaceutical
- 19.65
- +0.29+1.50%
Nanjing Hicin Pharmaceutical News
Nanjing Hicin Pharmaceutical: Announcement of the Supervisory Board's resolution.
Nanjing Hicin Pharmaceutical: Board of directors resolution announcement.
Nanjing Hicin Pharmaceutical: Announcement regarding abnormal fluctuations in stock trading.
Nanjing Hicin Pharmaceutical: Announcement of the resolutions of the 14th meeting of the 4th board of directors.
Nanjing Hicin Pharmaceutical: 2023 Online Results Briefing and Investor Relations Activity Record Form 20240507
Haichen Pharmaceutical: Announcement on renewing the 2024 Audit Institution
Haichen Pharmaceutical: Evaluation Report on the 2023 Performance Status of Accounting Firms
Haichen Pharmaceutical: 2023 Board Work Report
Haichen Pharmaceutical: 2023 Independent Director Debriefing Report (Mao Lingxiao)
Haichen Pharmaceutical: Announcement of Supervisory Board Resolutions
Haichen Pharmaceutical: 2023 Independent Director Debriefing Report (Zhao Ming)
Haichen Pharmaceutical: Tianheng Certified Public Accountants (Special General Partnership) Special Instructions on the Company's 2023 Non-operating Capital Occupation and Financial Transactions with Other Related Parties
Haichen Pharmaceutical: Announcement of Board Resolutions
Haichen Pharmaceutical: Announcement on the estimated amount of guarantee provided to subsidiary companies in 2024
Haichen Pharmaceutical: 2023 Independent Director Debriefing Report (Zhou Hao)
Haichen Pharmaceutical: 2023 Independent Director Debriefing Report (Li Xiang)
Haichen Pharmaceutical: Special opinion of the board of directors on the sole director's independence assessment
Haichen Pharmaceutical: 2023 Annual Audit Report
Haichen Pharmaceutical: Announcement on the Company\'s Obtaining a High-tech Enterprise Certificate
Haichen Pharmaceutical: Independent Director Work System (December 2023)
Analysis
Price Target
No Data
